One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Disparities in Cardiovascular Medicine
Michelle A. Albert, Mercedes R. Carnethon, Karol E. Watson
doi : 10.1161/CIRCULATIONAHA.121.055565
Circulation. 2021;143:2319–2320
A Pioneer in Transplantation Genomics, Inclusion, and Diversity: A Conversation With Hannah Valantine, MBBS, MD
Hannah Valantine, Maryjane Farr
doi : 10.1161/CIRCULATIONAHA.121.055501
Circulation. 2021;143:2321–2326
The Journey Toward Health Equity: Are We Nearing an Abyss or Ascending a Peak?
Clyde W. Yancy
doi : 10.1161/CIRCULATIONAHA.121.055157
Circulation. 2021;143:2327–2328
Sodium-Glucose Cotransporter-2 Inhibitors in Heart Failure: Racial Differences and a Potential for Reducing Disparities
Alanna A. Morris, Jeffrey M. Testani, Javed Butler
doi : 10.1161/CIRCULATIONAHA.120.052821
Circulation. 2021;143:2329–2331
Racial and Ethnic Differences in Presentation and Outcomes for Patients Hospitalized With COVID-19: Findings From the American Heart Association’s COVID-19 Cardiovascular Disease Registry
Fatima Rodriguez, Nicole Solomon, James A. de Lemos, Sandeep R. Das, David A. Morrow, Steven M. Bradley, Mitchell S.V. Elkind, Joseph H. Williams, DaJuanicia Holmes, Roland A. Matsouaka, Divya Gupta, Ty J. Gluckman, Marwah Abdalla, Michelle A. Albert, Clyde W. Yancy, Tracy Y. Wang
doi : 10.1161/CIRCULATIONAHA.120.052278
Circulation. 2021;143:2332–2342
The coronavirus disease 2019 (COVID-19) pandemic has exposed longstanding racial and ethnic inequities in health risks and outcomes in the United States. We aimed to identify racial and ethnic differences in presentation and outcomes for patients hospitalized with COVID-19.
To Solve Racial and Ethnic Disparities in COVID-19 Outcomes, Look Upstream for Solutions
Yvonne Commodore-Mensah, Deidra C. Crews
doi : 10.1161/CIRCULATIONAHA.120.052713
Circulation. 2021;143:2343–2345
Racial and Ethnic Disparities in Heart and Cerebrovascular Disease Deaths During the COVID-19 Pandemic in the United States
Rishi K. Wadhera, Jose F. Figueroa, Fatima Rodriguez, Michael Liu, Wei Tian, Dhruv S. Kazi, Yang Song, Robert W. Yeh, Karen E. Joynt Maddox
doi : 10.1161/CIRCULATIONAHA.121.054378
Circulation. 2021;143:2346–2354
Cardiovascular deaths increased during the early phase of the COVID-19 pandemic in the United States. However, it is unclear whether diverse racial/ethnic populations have experienced a disproportionate rise in heart disease and cerebrovascular disease deaths.
Association of Serum Aldosterone and Plasma Renin Activity With Ambulatory Blood Pressure in African Americans: The Jackson Heart Study
Joshua J. Joseph, Neal K. Pohlman, Songzhu Zhao, David Kline, Guy Brock, Justin B. Echouffo-Tcheugui, Mario Sims, Valery S. Effoe, Wen-Chih Wu, Rita R. Kalyani, Gary S. Wand, Bjorn Kluwe, Willa A. Hsueh, Marwah Abdalla, Daichi Shimbo, Sherita H. Golden
doi : 10.1161/CIRCULATIONAHA.120.050896
Circulation. 2021;143:2355–2366
The renin-angiotensin-aldosterone system (RAAS) is an important driver of blood pressure (BP), but the association of the RAAS with ambulatory BP (ABP) and ABP monitoring phenotypes among African Americans has not been assessed.
Physiological Treatment of Hypertension in Black Patients: Time for Action
Brian L. Rayner, J. David Spence
doi : 10.1161/CIRCULATIONAHA.121.053880
Circulation. 2021;143:2367–2369
Development and Validation of Machine Learning–Based Race-Specific Models to Predict 10-Year Risk of Heart Failure: A Multicohort Analysis
Matthew W. Segar, Byron C. Jaeger, Kershaw V. Patel, Vijay Nambi, Chiadi E. Ndumele, Adolfo Correa, Javed Butler, Alvin Chandra, Colby Ayers, Shreya Rao, Alana A. Lewis, Laura M. Raffield, Carlos J. Rodriguez, Erin D. Michos, Christie M. Ballantyne, Michael E. Hall, Robert J. Mentz, James A. de Lemos, Ambarish Pandey
doi : 10.1161/CIRCULATIONAHA.120.053134
Circulation. 2021;143:2370–2383
Heart failure (HF) risk and the underlying risk factors vary by race. Traditional models for HF risk prediction treat race as a covariate in risk prediction and do not account for significant parameters such as cardiac biomarkers. Machine learning (ML) may offer advantages over traditional modeling techniques to develop race-specific HF risk prediction models and to elucidate important contributors of HF development across races.
Cost-Effectiveness of Hypertension Treatment by Pharmacists in Black Barbershops
Kelsey B. Bryant, Andrew E. Moran, Dhruv S. Kazi, Yiyi Zhang, Joanne Penko, Natalia Ruiz-Negr?n, Pamela Coxson, Ciantel A. Blyler, Kathleen Lynch, Laura P. Cohen, Gabriel S. Tajeu, Valy Fontil, Norma B. Moy, Joseph E. Ebinger, Florian Rader, Kirsten Bibbins-Domingo, Brandon K. Bellows
doi : 10.1161/CIRCULATIONAHA.120.051683
Circulation. 2021;143:2384–2394
In LABBPS (Los Angeles Barbershop Blood Pressure Study), pharmacist-led hypertension care in Los Angeles County Black-owned barbershops significantly improved blood pressure control in non-Hispanic Black men with uncontrolled hypertension at baseline. In this analysis, 10-year health outcomes and health care costs of 1 year of the LABBPS intervention versus control are projected.
Racial Diversity Among American Cardiologists: Implications for the Past, Present, and Future
Amber E. Johnson, Mehret Birru Talabi, Eliana Bonifacino, Alison J. Culyba, Esa M. Davis, Paula K. Davis, Laura M. De Castro, Utibe R. Essien, Alda Maria Gonzaga, MaCalus V. Hogan, Alaina J. James, Charles R. Jonassaint, Naudia L. Jonassaint, Loreta Matheo, Melonie A. Nance, G. Sarah Napoé, Oladipupo Olafiranye, Sylvia Owusu-Ansah, Tomar N. Pierson-Brown, A.J. Conrad Smith, Tomeka L. Suber, Orquidia Torres, Rickquel Tripp, Eloho Ufomata, J. Deanna Wilson, Jeannette E. South-Paul
doi : 10.1161/CIRCULATIONAHA.121.053566
Circulation. 2021;143:2395–2405
In the United States, race-based disparities in cardiovascular disease care have proven to be pervasive, deadly, and expensive. African American/Black, Hispanic/Latinx, and Native/Indigenous American individuals are at an increased risk of cardiovascular disease and are less likely to receive high-quality, evidence-based medical care as compared with their White American counterparts. Although the United States population is diverse, the cardiovascular workforce that provides its much-needed care lacks diversity. The available data show that care provided by physicians from racially diverse backgrounds is associated with better quality, both for minoritized patients and for majority patients. Not only is cardiovascular workforce diversity associated with improvements in health care quality, but racial diversity among academic teams and research scientists is linked with research quality. We outline documented barriers to achieving workforce diversity and suggest evidence-based strategies to overcome these barriers. Key strategies to enhance racial diversity in cardiology include improving recruitment and retention of racially diverse members of the cardiology workforce and focusing on cardiovascular health equity for patients. This review draws attention to academic institutions, but the implications should be considered relevant for nonacademic and community settings as well.
Scaling Up Pharmacist-Led Blood Pressure Control Programs in Black Barbershops: Projected Population Health Impact and Value
Dhruv S. Kazi, Pengxiao C. Wei, Joanne Penko, Brandon K. Bellows, Pamela Coxson, Kelsey B. Bryant, Valy Fontil, Ciantel A. Blyler, Courtney Lyles, Kathleen Lynch, Joseph Ebinger, Yiyi Zhang, Gabriel S. Tajeu, Ross Boylan, Mark J. Pletcher, Florian Rader, Andrew E. Moran, Kirsten Bibbins-Domingo
doi : 10.1161/CIRCULATIONAHA.120.051782
Circulation. 2021;143:2406–2408
Diverse Racial/Ethnic Group Underreporting and Underrepresentation in High-Impact Cholesterol Treatment Trials
Ashish Sarraju, Areli Valencia, Joshua W. Knowles, David J. Maron, Fatima Rodriguez
doi : 10.1161/CIRCULATIONAHA.120.050034
Circulation. 2021;143:2409–2411
Imbalance in Heart Transplant to Heart Failure Mortality Ratio Among African American, Hispanic, and White Patients
Khadijah Breathett, Shannon M. Knapp, Molly Carnes, Elizabeth Calhoun, Nancy K. Sweitzer
doi : 10.1161/CIRCULATIONAHA.120.052254
Circulation. 2021;143:2412–2414
